Yes, there is improvement in the writing, but I don't see how it...

Yes, there is improvement in the writing, but I don't see how it could have been otherwise...

That said, I was expecting more substance. This one doesn't say much more than the previous 'top line' one. Maybe, my expectation was wrong ??

The results in percentage terms look good but the number of patients look tiny - but we already knew that.

As it was said many times before in this thread, the key is partnership with big pharma, so hopefully this announcement will help.

I can't help thinking about the Tibotec move at the end of this month. Even if ATC is not in the middle of the negotiations with Tibotec, a deal with Tibotec would give AVX lots of credibility and would, I think, boost the chances of an ATC deal happening. Of course, it would be even simpler if ATC was to be part of it, and lead to some sort of takeover/merger from J&J.

A pity that the sp went south so badly in the recent week - 10, 20 or 30% jump on 13c won't take us where we need to be.